Harvard Says It Is Not Divesting From Israel
Harvard University said the sale of some of its investments in Israel was not politically motivated and it is not divesting from Israel.
Harvard spokesman John Longbrake told Foreign Policy that the university sold $39 million in stocks in five Israeli companies because Israeli stocks could no longer be considered part of the emerging markets portfolio, where they previously had been held.
“The university has not divested from Israel,” Longbrake said. “Israel was moved from the MSCI, our benchmark in emerging markets, to the EAFE index in May due to its successful growth. Our emerging markets holdings were rebalanced accordingly.”
He said Harvard is still invested in Israel but declined to go into specifics.
According to Foreign Policy, several of the stocks that were sold – Teva Pharmaceutical Industries, NICE Systems, Check Point Software Technologies, Cellcom Israel and Partner Communications – were doing poorly.
Nevertheless, the Boycott, Divestment and Sanctions for Palestine movement claimed a victory, according to Foreign Policy. The BDS campaign targets Israeli consumer, academic, cultural and sports organizations.
The Anti-Defamation League said the BDS campaign also claimed that Hampshire College divested from Israel in February 2009 – a claim that was rejected by the college.
This is a moment of great uncertainty. Here’s what you can do about it.
We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover.
This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.
With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.
The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.
Support our mission to tell the Jewish story fully and fairly.
